KIORA PHARMACEUTICALS, INC. Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
KIORA PHARMACEUTICALS, INC. (KPRX) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2017-02-23
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2016-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2016-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2016-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2016 was $0.00.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2015 was -$27.79K, a 112.39% decline from fiscal 2014.
- KIORA PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to noncontrolling interest for fiscal 2014 was $224.37K.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | -$27.79K 10-K · filed 2017-02-23 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | -$27.79K 10-Q · filed 2016-11-01 | $149.87K derived: sum of 4 quarters · filed 2016-11-01 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | -$27.79K 10-Q · filed 2016-08-10 | $149.87K derived: sum of 3 quarters · filed 2016-08-10 | $103.78K derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | $27.79K 10-Q · filed 2016-05-13 | -$27.79K 10-Q · filed 2015-05-18 | $149.87K derived: sum of 2 quarters · filed 2016-05-13 | $103.78K derived: sum of 3 quarters · filed 2016-05-13 | $186.40K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $122.08K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $75.98K derived: sum of 2 quarters · filed 2016-03-30 | $158.61K derived: sum of 3 quarters · filed 2016-03-30 | $224.37K 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$46.10K 10-Q · filed 2015-11-12 | $36.52K derived: sum of 2 quarters · filed 2015-11-12 | $102.29K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $82.62K 10-Q · filed 2015-08-12 | $148.39K 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | $65.77K 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |